Correlation Between Rocket Pharmaceuticals and Stoke Therapeutics

Can any of the company-specific risk be diversified away by investing in both Rocket Pharmaceuticals and Stoke Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Rocket Pharmaceuticals and Stoke Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Rocket Pharmaceuticals and Stoke Therapeutics, you can compare the effects of market volatilities on Rocket Pharmaceuticals and Stoke Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Rocket Pharmaceuticals with a short position of Stoke Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Rocket Pharmaceuticals and Stoke Therapeutics.

Diversification Opportunities for Rocket Pharmaceuticals and Stoke Therapeutics

0.48

Correlation Coefficient

Rocket Pharmaceuticals  Stoke Therapeutics

Very weak diversification

The 3 months correlation between Rocket and Stoke is 0.48. Overlapping area represents the amount of risk that can be diversified away by holding Rocket Pharmaceuticals and Stoke Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Stoke Therapeutics and Rocket Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Rocket Pharmaceuticals are associated (or correlated) with Stoke Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Stoke Therapeutics has no effect on the direction of Rocket Pharmaceuticals i.e., Rocket Pharmaceuticals and Stoke Therapeutics go up and down completely randomly.

Pair Corralation between Rocket Pharmaceuticals and Stoke Therapeutics

Given the investment horizon of 90 days Rocket Pharmaceuticals is expected to under-perform the Stoke Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Rocket Pharmaceuticals is 1.1 times less risky than Stoke Therapeutics. The stock trades about -0.23 of its potential returns per unit of risk. The Stoke Therapeutics is currently generating about -0.03 of returns per unit of risk over similar time horizon. If you would invest  1,327  in Stoke Therapeutics on September 23, 2024 and sell it today you would lose (159.00) from holding Stoke Therapeutics or give up 11.98% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Rocket Pharmaceuticals  vs.  Stoke Therapeutics

Rocket Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Rocket Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's forward-looking signals remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Stoke Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Stoke Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest unsteady performance, the Stock's basic indicators remain persistent and the latest mess on Wall Street may also be a sign of long-standing gains for the company institutional investors.

Pair Trading with Rocket Pharmaceuticals and Stoke Therapeutics

The main advantage of trading using opposite Rocket Pharmaceuticals and Stoke Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Rocket Pharmaceuticals position performs unexpectedly, Stoke Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Stoke Therapeutics will offset losses from the drop in Stoke Therapeutics' long position.

The idea behind Rocket Pharmaceuticals and Stoke Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.